Optimization of a CRISPR-based metabolic pathway for enhanced biosynthesis of a high-value bioproduct in a cyanobacterial system.

Project Abstract

Optimization of a CRISPR-based metabolic pathway in a cyanobacterial chassis to enhance biosynthesis of a high-value bioproduct is demonstrated through a systematic engineering framework that integrates genome-scale metabolic modeling, precise CRISPR-CR somatic editing, and dynamic regulation of flux through photosynthetically powered pathways. The study employs CRISPR interference and activation (CRISPRi/a) to modulate native regulatory nodes and heterologous pathway components, enabling tunable expression with minimized metabolic burden. A robust design-build-test-learn cycle is implemented, incorporating modular plasmid architectures, multiplexed guide RNA libraries, and switchable promoter systems to achieve combinatorial optimization of precursor supply, cofactor balance, and product sequestration. We first reconstructed a high-resolution metabolic map of the cyanobacterial host under varying light intensities and carbon flux conditions to identify bottlenecks and key regulation points governing flux toward the target metabolite. Using dynamic flux balance analysis, we predict CRISPRi-mediated downregulation of competing pathways and CRISPRa-mediated upregulation of rate-limiting enzymes yields higher theoretical yields with improved redox and ATP economy. Guided by in silico insights, we engineered a minimal, codon-optimized heterologous pathway anchored to plastid-like compartments and integrated it into a stable genomic locus to ensure heritable expression. Regulatory circuits were designed to respond to intracellular metabolite cues and photosynthetic activity, enabling autonomous tuning of pathway flux in response to diurnal cycles. Experimental results demonstrate a significant increase in product titer and yield relative to baseline strains, with a concurrent reduction in byproduct formation. Real-time metabolomics and targeted proteomics validated the rebalanced flux distribution, while transcriptome profiling confirmed targeted regulation with minimal off-target effects. We observed improved carbon efficiency under semi-continuous cultivation, with the system maintaining robust growth and photosynthetic performance, highlighting the feasibility of CRISPR-based metabolic fine-tuning in cyanobacteria for scalable bioproduction. The study also assesses biosafety and genetic stability over extended cultivation, showing stable trait maintenance and negligible horizontal transfer risk under the tested conditions. Comparative analyses against conventional overexpression strategies reveal that CRISPRi/a-based control achieves greater metabolic flexibility, reduced cellular stress, and lower energy penalty, translating to higher net product accumulation per mole of fixed carbon. Additionally, the work provides a transferable framework for deploying multiplexed CRISPR strategies in photosynthetic microorganisms to optimize complex, multi-enzyme pathways and demonstrates the potential for engineering cyanobacteria to serve as sustainable biofactories for high-value bioproducts with reduced resource footprints. The findings advance the understanding of regulatory and flux-control principles in photosynthetic metabolism and establish actionable design rules for rapid prototyping of CRISPR-enabled bioproduction in cyanobacteria.

Project Overview

What This Project Is About

---

A straightforward, low-jargoon overview of how a tiny genetic tool called CRISPR can tweak a cyanobacteria’s metabolism to make more of a useful product. The project looks at identifying which metabolic steps limit production, adjusting gene activity, and measuring how changes impact yield and purity of the bioproduct.

---

---

The Problem It Addresses

---

Cyanobacteria naturally convert sunlight and carbon dioxide into various compounds, but getting them to put more effort into making a specific, valuable product is inefficient. The project tackles the bottlenecks in the metabolic pathway and aims to increase the amount of product without harming the organism, addressing both economic viability and sustainability.

---

---

Objectives of the Project

---

1. Identify the limiting steps in the cyanobacterial metabolic pathway toward the target product.
2. Design simple CRISPR-based tweaks to adjust enzyme levels safely.
3. Evaluate how changes affect product yield, rate, and purity.
4. Assess the stability of modifications over time and under light exposure.
5. Propose a scalable approach for potential larger studies.

---

---

What You Will Do Step by Step

---

1. Review basic literature on cyanobacteria and CRISPR tools used in metabolism.
2. Select a target product and map its production pathway.
3. Design CRISPR edits to tune key enzymes and test in a safe lab setup.
4. Grow edited strains under controlled light and nutrient conditions.
5. Measure product levels and cell health; compare with controls.
6. Analyze data for trends and potential off-target effects.
7. Document methods, results, and limitations to guide future work.

---

---

Expected Outcome

Anticipated results include higher yield of the bioproduct with acceptable purity, a better understanding of which edits work best, and a clear set of practical steps for future optimization or scaling.